Background. The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. Methods. We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. Results. At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P < .001). Conclusions. Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.

Di Pasquale M.F., Sotgiu G., Gramegna A., Radovanovic D., Terraneo S., Reyes L.F., et al. (2019). Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. CLINICAL INFECTIOUS DISEASES, 68(9), 1482-1493 [10.1093/cid/ciy723].

Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

Battaglia S.
Membro del Collaboration Group
;
2019-01-01

Abstract

Background. The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. Methods. We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. Results. At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P < .001). Conclusions. Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.
Settore MED/10 - Malattie Dell'Apparato Respiratorio
http://cid.oxfordjournals.org/content/by/year
Di Pasquale M.F., Sotgiu G., Gramegna A., Radovanovic D., Terraneo S., Reyes L.F., et al. (2019). Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. CLINICAL INFECTIOUS DISEASES, 68(9), 1482-1493 [10.1093/cid/ciy723].
File in questo prodotto:
File Dimensione Formato  
VQR Prevalence and Etiology of Community-1-4.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 3.37 MB
Formato Adobe PDF
3.37 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
VQR Prevalence and Etiology of Community-5-8.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 8.12 MB
Formato Adobe PDF
8.12 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
VQR Prevalence and Etiology of Community-9-12.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 116.03 kB
Formato Adobe PDF
116.03 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/401982
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 55
social impact